385
Participants
Start Date
March 25, 2021
Primary Completion Date
April 30, 2023
Study Completion Date
April 30, 2023
Novaferon
a novel recombinant antiviral protein drug
Placebo
Saline
RECRUITING
Chiba Aoba Municipal Hospital, Chiba
RECRUITING
Kamagaya General Hospital, Chiba
RECRUITING
NHO Chiba Medical Center, Chiba
ACTIVE_NOT_RECRUITING
NHO Omuta National Hospital, Fukuoka
RECRUITING
NHO Kasumigaura Medical Center, Ibaraki
ACTIVE_NOT_RECRUITING
Tsukuba Medical Center Foundation Tsukuba Medical Center Hospital, Ibaraki
RECRUITING
Kokankai Nippon Kokan Hospital, Kanagawa
RECRUITING
Rakuwakai Otowa Hospital, Kyoto
RECRUITING
Okayama City General Medical Center Okayama City Hospital, Okayama
RECRUITING
Osaka Habikino Medical Center, Osaka
RECRUITING
Rinku General Medical Center, Osaka
RECRUITING
Sakai City Medical Center, Osaka
RECRUITING
Omi Medical Center, Shiga
ACTIVE_NOT_RECRUITING
NHO Utsunomiya Hospital, Tochigi
ACTIVE_NOT_RECRUITING
Japanese Red Cross Medical Center, Tokyo
ACTIVE_NOT_RECRUITING
Juntendo University Hospital, Tokyo
ACTIVE_NOT_RECRUITING
Nihon University Itabashi Hospital, Tokyo
ACTIVE_NOT_RECRUITING
Showa University East Hospital, Tokyo
RECRUITING
Showa University Hospital, Tokyo
RECRUITING
Tokyo Medical University Hachioji Medical Center, Tokyo
RECRUITING
Tokyo Shinagawa Hospital, Tokyo
RECRUITING
NHO Iwakuni Clinical Center, Yamaguchi
Lead Sponsor
Genova Inc.
INDUSTRY